Cecilia C. Low Wang, MD, FACP, previews her presentation “Management of Steroid-Associated Hyperglycemia in Inpatient and Outpatient Settings,” which begins at 11:40 a.m. CT Saturday, June 13. Read more

Korey Hood, PhD, previews his presentation “Is One Size Fits All Actually A Bad Approach?” which beings at 4:30 p.m. CT Saturday, June 13. Read more

Bruce Verchere, PhD, previews his presentation “Pro-Islet Amyloid Polypeptide Processing in Diabetes,” which begins at 2:45 p.m. CT Saturday, June 13. Read more

Clipper F. Young, PharmD, MPH, CDCES, BC-ADM, BCGP, previews the Professional Interest Group Discussion “Diabetes Self-Management Education and Support (DSMES)—Focus on 2020 DSMES Consensus Report,” which begins at 12:00 p.m. CT Sunday, June 14. Read more

Sarah Hallberg, DO, MS, ACSM-CEP, FOMA, FNLA, previews her presentation “Dietary Fat as a Cause of Metabolic Disease,” which begins at 11:30 a.m. CT Friday, June 12. Read more

Elias Spanakis, MD, previews his presentation “Use of Continuous Glucose Monitoring Devices in the Hospital—Time for Glucose Telemetry?” which begins at 12:05 p.m. CT Saturday, June 13. Read more

Edward C. Chao, DO, previews the Professional Interest Group Discussion “Clinical Centers and Programs — Frequently Encountered Glycemic Management Issues without Clear Guidelines,” for which he is the chair. The session begins at 11:30 p.m. CT Saturday, June 13. Read more

The International Hypoglycemia Study Group recently proposed a revised classification of hypoglycemia that has been adopted by the ADA, the European Association for the Study of Diabetes, and a number of other organizations. Simon R. Heller, MD, FRCP, discusses the rationale behind the IHSG’s proposed definitions, how these definitions have impacted current guidelines, and what steps still need to be taken to adopt a universal hypoglycemia definition. Read more

Mary de Groot, PhD, previews her address as ADA President of Health Care and Education, “50 Years of Behavioral Science in Diabetes—A 2020 Vision of the Future,” which begins at 10:15 a.m. CT Saturday, June 13. Read more

Marc Reitman, MD, PhD, previews his presentation “Burn It Up—Temperature and Obesity Treatment,” which begins at 9:00 a.m. CT Saturday, June 13. Read more

Marzieh Salehi, MD, MS, FACP, previews her presentation “Complications of Bariatric Surgery—Hypoglycemia Pathophysiology and Management,” which begins at 5:15 p.m. CT Friday, June 12. Read more

Persis V. Commissariat, PhD, previews her presentation “‘Adulting’ with Diabetes: Things to Teach the Hard-to-Reach,” which begins at 11:50 a.m. CT Friday, June 12. Read more

Jennifer Saylor, PhD, APRN, ACNS-BC, previews her presentation, “Using Lived Experiences as a Mechanism for Engagement in Diabetes Care,” which begins at 11:30 a.m. CT Friday, June 12. Read more

Jenise C. Wong, MD, PhD, previews the Professional Interest Group Discussion “Diabetes Technology—Interpreting Time-in-Range in Different Populations and Situations,” which begins at 12:00 p.m. CT Monday, June 15. Read more

Matthias Kretzler, MD, previews his presentation “The Value of Kidney Biopsies to Empower New Discoveries in Diabetic Kidney Disease: Insight into COVID-19 kidney damage,” which begins at 4:30 p.m. CT Monday, June 15. Read more

Ana Domingos, PhD, previews her presentation “Sympathetic-Associated Macrophages in Energy Homeostasis,” which begins at 5:00 p.m. CT Saturday, June 13. Read more

John JV McMurray, OBE, BSc (Hons), MB, ChB (Hons), MD, Professor of Medical Cardiology, University of Glasgow, previews his presentation “DAPA-HF Update—Have We Lost SGLT2 Inhibitors to Cardiologists?! Background and Main Cardiovascular Outcomes,” which begins at 4:00 p.m. CT Saturday, June 13. Read more

Eran Segal, PhD, previews his presentation “Efficacy of Personalized Nutrition Based on Gut Microbiome and Clinical Data in Prediabetes,” which begins at 11:40 a.m. CT Saturday, June 13. Read more

Guoxun Chen, PhD, previews his response and discussion from the Professional Interest Group Discussion “Nutritional Science and Metabolism—Emerging Methodologies for Personalized Nutrition—Potential Effects on Glycemic and Other Diabetes-Related Outcomes?” The session begins at 11:30 a.m. CT Saturday, June 13. Dr. Chen’s presentation will begin at 12:10 p.m. CT. Read more

John JV McMurray, OBE, BSc (Hons), MB, ChB (Hons), MD, Professor of Medical Cardiology, University of Glasgow, previews his presentation “The Bexagliflozin Efficacy and Safety Trial (BEST): A Randomized, Double-Blind, Placebo-Controlled, Phase IIII, Clinical Trial,” which begins at 6 p.m. CT Friday, June 12. Read more

Linda A. Barbour, MD, MSPH, FACP, Professor of Endocrinology and Maternal-Fetal Medicine, University of Colorado Anschutz Medical Campus, previews her presentation “Oral Agents for Gestational Diabetes Mellitus—Are We Stuck Using Insulin?” which begins at 1:15 p.m. CT Friday, June 12. Read more

Josep Vehí, PhD, previews his presentation “AI for Risk Assessment and Blood Glucose Control,” which begins at 2:15 p.m. CT Monday, June 15. Read more

Joan K. Bardsley, MBA, RN, CDCES, FAADE, previews her presentation “Call to Action—Recommendations and the Four Critical Times,” which begins at 12:40 p.m. Sunday, June 14, and is part of Professional Interest Group Discussion on Diabetes Self-Management Education and Support (DSMES)—Focus on 2020 DSMES Consensus Report. Read more

During the Scientific Sessions, Scott A. Summers, PhD, reviewed the strong association of serum ceramides with insulin resistance and major adverse cardiac events. He also discussed new therapeutic approaches to lower ceramides and combat diabetes and its comorbidities. Read more

Erin Phillips, MPH, RDN, CDCES, previews her presentation “Definition and Benefits of a Weight-Neutral Approach,” which begins at 12:45 p.m. CT Friday, June 12. Read more

Emma E. Hamilton-Williams, PhD, describes results from the TOGeTHER Trial of type 1 diabetes patients, who were treated with a specially modified dietary fiber designed to deliver short-chain fatty acids into the large intestine. Her presentation details the impact of the supplement on the gut bacteria and diabetes management of the participants, revealing a promising new avenue for type 1 diabetes therapy. Read more

John JV McMurray, OBE, BSc (Hons), MB, ChB (Hons), MD, Professor of Medical Cardiology, University of Glasgow, previews his presentation “What Do We Know about the Effects of Antihyperglycemic Medication on Heart Failure?” which begins at 2:35 p.m. CT Friday, June 12. Read more

Jessica L. Turton, APD, BAppSc (Ex&SpSc), MNutriDiet, previews her presentation “Low-Carbohydrate Diets and Nutritional Ketosis,” which begins at 2:30 p.m. CT Friday, June 12. Read more

John M. Dennis, PhD, previews his presentation “Precision Medicine in Type 2 Diabetes—Using Individualized Prediction Models to Optimize Selection of Treatment,” which begins at 8:30 a.m. CT Sunday, June 14. Read more

Tiffany L. Gary-Webb, PhD, MHS, previews her presentation “Built Environment and Disadvantaged Communities,” which begins at 12:40 p.m. CT Monday, June 15. Read more

Matthew J. Budoff, MD, Professor of Medicine, University of California, Los Angeles, School of Medicine, previews his presentation “When Should You Order Coronary Artery Calcium (CAC) Scans?,” which begins at 12:00 CT Friday, June 12. Read more

Teresa Rodriguez-Calvo, DVM, PhD, previews her presentation “Histologic Analysis of Prohormone Processing,” which begins at 3:15 p.m. CT Saturday, June 13. Read more

Anath Shalev, MD, previews her presentation “Beta Cells Releasing Information,” which begins at 3:15 p.m. CT Monday, June 15. Read more

Arianna Dagliati, PhD, previews her presentation “Use of AI to Screen for Complications,” which begins at 3:35 p.m. CT Monday, June 15. Read more

Gretchen Benson, RDN, CDCES, discussed how a team-based approach featuring an expanded role for registered dietitian nutritionists (RDN) can help patients with type 2 diabetes, hypertension, and hyperlipidemia achieve better outcomes. She highlighted results from several studies demonstrating the benefits of expanding the role of RDNs in initiating/titrating medications. Read more

Sarit Polsky, MD, MPH, previews her presentation “Effects of Diabetes on Menopause Onset and Symptoms and Osteoporosis,” which begins at 5:10 p.m. CT Sunday, June 14. Read more

Richard E. Pratley, MD, previews “Effect of Oral Semaglutide With or Without Background SGLT2i in Patients with T2D: Subgroup Analysis of PIONEER 4,” which will begin at 10:00 a.m. CT Saturday, June 13. Read more

Laurel H. Messer, PhD, RN, previews her session “Educating Patients to Succeed with Advanced Pump Therapy,” which will begin at 9:00 a.m. CT Monday, June 15. Read more

Amy E. Rothberg, MD, PhD, previews her presentation “Financial Incentives for Weight Management,” which will begin at 8:00 a.m. CT Tuesday, June 16. Read more

Jamie L. Marshall, PhD, previews her presentation “Interrogation of Kidney Disease with Spatial Transcriptomics,” which begins at 5:30 p.m. CT Monday, June 15. Read more

William B. Horton, MD, FACP, previews his presentation “Hyperglycemia Increases Central Aortic Stiffness in Response to Insulin in Healthy Humans,” which will begin at 3:30 p.m. CT Monday, June 15. Read more

Rayhan Lal, MD, previews his presentation “Do-It-Yourself/Do-It-Together,” which will start at 12 p.m. CT Sunday, June 14, and is part of the Professional Interest Group Discussion on Diabetes in Youth—"Do-It-Yourself"/"Do-It-Together" (DIY/DIT) Closed-Loop Systems in Youth. Read more

Deepak K. Jumani, MBBS, FCGP, previews his presentation “Medical Management of Erectile Dysfunction,” which will begin at 1:15 p.m. CT Friday, June 12. Read more

Marisa E. Hilliard, PhD, discussed the concept of integrating positive psychology approaches into diabetes interventions during the Scientific Sessions. She presented research on intervention strategies designed to promote resilience in teens with diabetes by targeting family and health care systems. Read more

William B. Horton, MD, FACP, previews his presentation “Excess Heart Failure and Cardiovascular Disease Risk in Women with Diabetes—A Not-So-Sweet Truth,” which begins at 12:00 p.m. CT Sunday, June 14. Read more

Feyza Engin, PhD, examined beta-cell endoplasmic reticulum stress in type 1 diabetes during the Scientific Sessions. Although immune dysregulation plays a vital role in type 1 diabetes pathogenesis, emerging data suggest that beta cells are not passive bystanders but play an active role in their own demise, she said. Read more

M. Sue Kirkman, MD, previews the “NDEP Symposium—How Do We Focus on Consensus Rather Than Controversy? Guiding Principles for the Care of People with or at Risk for Diabetes,” which […] Read more

Anna L. Gloyn, DPhil, previews her presentation “Insights into Pancreatic Beta-Cell Function from Type 2 Diabetes GWAS,” which begins at 4:00 p.m. Saturday in W-2002 (West, Level 2). Read more

Julie A. Lovshin MD, PhD, previews her presentation "Renal Effects of GLP-1 Receptor Agonists: From Basic Mechanisms to Clinical Data," which begins at 1:45 p.m. Saturday in N-Hall E (North, Exhibition Level). Read more

Judith G. Regensteiner, PhD, previews her presentation “Researcher’s Perspective—Exercise Effects on Resolving the Underlying Mechanism That Drive Cardiovascular Complications Associated with Diabetes,” which begins at 12:05 p.m. Friday in S-10 (South, Exhibition Level). Read more

Joyce M. Lee, MD, MPH, previews her presentation “Do Not Fear—Social Media for Promoting Your Science," which begins at 12:45 p.m. Friday in S-208 (South, Level 2) during the Women’s Interprofessional Network of the ADA (WIN ADA) Mini-Symposium—Using Tools and Strategies to Effectively Communicate Science. Read more

John R. Petrie, PhD, FRCP, previews the session “Digital Apps for Diabetes Prevention—Opportunities and Challenges,” which begins at 12:45 p.m. Friday in W-2009 (West, Level 2). Read more

Anne L. Peters, MD, provides a preview of her presentation "Continuous Glucose Monitoring in Special Populations—Benefits and Barriers," which begins at 5:15 p.m. Friday in N-Hall E (North, Exhibition Level). Read more

Kelly Rawlings, MPH, previews the session “ADA Nutrition Therapy for Adults with Diabetes—2019 Consensus Paper,” which begins at 8:00 a.m. Saturday in S-203 (South, Level 2). Read more

Janice MacLeod, MA, RD, CDE, FAADE, previews her presentation “Are Nutrition and Diabetes Education Interventions Effective in Improving Outcomes?” which begins at 8:05 a.m. Saturday in S-203 (South, Level 2) during the session “ADA Nutrition Therapy for Adults with Diabetes—2019 Consensus Paper.” Read more

Julie A. Lovshin, MD, PhD, previews her presentation "Renal Effects of GLP-1 Receptor Agonists: From Basic Mechanisms to Clinical Data," which begins at 1:45 p.m. Saturday in N-Hall E (North, Exhibition Level). Read more

Anna L. Gloyn, DPhil, previews her presentation “Insights into Pancreatic Beta-Cell Function from Type 2 Diabetes GWAS,” which begins at 4:00 p.m. Saturday in W-2002 (West, Level 2). Read more

M. Sue Kirkman, MD, previews the “NDEP Symposium—How Do We Focus on Consensus Rather Than Controversy? Guiding Principles for the Care of People with or at Risk for Diabetes,” which begins at 8:00 a.m. Sunday in S-208 (South, Level 2). Read more

Steven Edelman, MD, previews the late-breaking poster “Burden of Cardiovascular Comorbidity in U.S. Adults with T1D,” which will be displayed at 12:00 p.m. Sunday in the Poster Hall (Hall F, North, Exhibition Level). Read more

Nuha A. ElSayed, MD, MMSc, previews her presentation “The Science of Learning—Demystifying Memory, Retention, and Behavior Change,” which begins at 12:00 p.m. Sunday in S-10 (South, Exhibition Level). Read more

Jane Speight, PhD, previews her presentation “Strategies to Improve Communication between Patient and Provider,” which begins at 6:00 p.m. Sunday in S-203 (South, Level 2). Read more